Home688136 • SHA
add
Kexing Biopharm Co Ltd
Previous close
¥17.29
Day range
¥16.54 - ¥17.41
Year range
¥10.61 - ¥22.82
Market cap
3.31B CNY
Avg Volume
1.92M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 278.36M | -13.02% |
Operating expense | 167.91M | -22.67% |
Net income | 5.30M | 178.49% |
Net profit margin | 1.90 | 190.05% |
Earnings per share | — | — |
EBITDA | 35.03M | 46.53% |
Effective tax rate | 45.80% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 468.21M | -23.57% |
Total assets | 3.00B | -5.56% |
Total liabilities | 1.38B | -2.11% |
Total equity | 1.62B | — |
Shares outstanding | 197.32M | — |
Price to book | 2.11 | — |
Return on assets | 1.41% | — |
Return on capital | 1.53% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 5.30M | 178.49% |
Cash from operations | 87.30M | 590.40% |
Cash from investing | -113.54M | 23.75% |
Cash from financing | -107.32M | -42.81% |
Net change in cash | -133.80M | 36.55% |
Free cash flow | -47.74M | 39.88% |
About
Founded
1989
Website
Employees
1,014
